Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
1(14%)
Results Posted
100%(2 trials)
Terminated
1(14%)

Phase Distribution

Ph early_phase_1
1
14%
Ph not_applicable
1
14%
Ph phase_2
1
14%
Ph phase_3
1
14%
Ph phase_4
2
29%

Phase Distribution

1

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
2(33.3%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(3)
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Not yet recruiting2
Recruiting1
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 31 (16.7%)
Phase 42 (33.3%)
N/A1 (16.7%)

Trials by Status

completed229%
not_yet_recruiting229%
recruiting114%
terminated114%
unknown114%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DRUG
Total Trials
7